SciClone differentiated therapies for oncology, infectious diseases and cardiovascular, urological, respiratory, and central nervous system disorders.
Business Model:
Revenue: $172M
Employees: 501-1,000
SciClone was acquired by
GL Capital.
The acquisition happend on 2017-06-08.
Details of the transaction were not public
Address: 950 Tower Ln
City: Foster City
State: CA
Zip: 94404
Country: US
SciClone differentiated therapies for oncology, infectious diseases and cardiovascular, urological, respiratory, and central nervous system disorders.
Contact Phone:
+16503583456
Contact Email:
Listed Exchange:
Hong Kong Stock Exchange
IPO Date:
3/3/2021
Ticker Symbol:
6600
IPO Price:
$2.423832982436236/share
Amount Raised:
$263M
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
12/2020 | Ability Pharmaceuticals | Corporate Round | 3M |
12/2020 | Ability Pharmaceuticals | Corporate Round | 0 |
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 3/2021 | IPO | $279M |
|
2/2021 | Venture Round | $0 |
Grand View Capital IDG Capital Opportunity Fund Shanghai Pharmaceutical Grand View Capital IDG Capital Opportunity Fund Shanghai Pharmaceutical |
2/2021 | Venture Round | 4 | $134M |
Grand View Capital IDG Capital Opportunity Fund Shanghai Pharmaceutical Grand View Capital IDG Capital Opportunity Fund Shanghai Pharmaceutical |
---|
Announced Date | Name | Price |
---|---|---|
4/2011 | NovaMed Pharmaceuticals |
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|